DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental products and technologies, and other consumable dental products and equipment primarily for the professional dental market worldwide. More Details
Short Term Liabilities: XRAY's short term assets ($1.8B) exceed its short term liabilities ($1.3B).
Long Term Liabilities: XRAY's short term assets ($1.8B) do not cover its long term liabilities ($3.1B).
Debt to Equity History and Analysis
Debt Level: XRAY's debt to equity ratio (45.8%) is considered high.
Reducing Debt: XRAY's debt to equity ratio has reduced from 46.7% to 45.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable XRAY has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: XRAY is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 1.5% per year.
What is DENTSPLY SIRONA current dividend yield, its reliability and sustainability?
0.67%
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: XRAY's dividend (0.67%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.31%).
High Dividend: XRAY's dividend (0.67%) is low compared to the top 25% of dividend payers in the US market (3.64%).
Stability and Growth of Payments
Stable Dividend: XRAY is not paying a notable dividend for the US market, therefore no need to check if payments are stable.
Growing Dividend: XRAY is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: XRAY is not paying a notable dividend for the US market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of XRAY's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
2.5yrs
Average management tenure
CEO
Don Casey (60 yo)
3.08yrs
Tenure
US$11,366,243
Compensation
Mr. Donald M. Casey, Jr., also known as Don, serves as CEO and Director at DENTSPLY International Inc., since 2018. Mr. Casey has been Chief Executive Officer and a Director at Dentsply Sirona Inc. since ...
CEO Compensation Analysis
Compensation vs Market: Don's total compensation ($USD11.37M) is about average for companies of similar size in the US market ($USD10.58M).
Compensation vs Earnings: Don's compensation has increased whilst the company is unprofitable.
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Donald Casey
CEO & Director
3.08yrs
US$11.37m
0.045% $ 5.9m
Jorge Gomez
Executive VP & CFO
1.58yrs
US$10.30m
0.016% $ 2.0m
Keith Ebling
Executive VP
3.42yrs
US$4.61m
0.0037% $ 488.9k
Walter Petersohn
Senior VP & Chief Commercial Officer
3.67yrs
US$3.11m
0.020% $ 2.7m
Ranjit Chadha
Chief Accounting Officer
0.58yr
no data
no data
Cord Staehler
Senior VP Digital Platforms & Solutions and CTO
1.83yrs
no data
0.0018% $ 230.0k
John Sweeney
Vice President of Investor Relations
no data
no data
no data
Lisa Yankie
Senior VP and Chief HR Officer & Communications
1.42yrs
no data
0.0022% $ 290.5k
Chidam Chidambaram
Senior VP
1.83yrs
no data
0.0050% $ 655.8k
Albert Sterkenburg
Senior Vice President
12.17yrs
US$1.35m
no data
Teresa Dolan
Chief Clinical Officer & VP
no data
no data
no data
Markus Boehringer
Senior Vice President of EMEA RCO
3.67yrs
US$1.52m
no data
2.5yrs
Average Tenure
52.5yo
Average Age
Experienced Management: XRAY's management team is considered experienced (2.5 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
Donald Casey
CEO & Director
3.08yrs
US$11.37m
0.045% $ 5.9m
Francis Lunger
Independent Director
15.83yrs
US$326.95k
0.012% $ 1.5m
Eric Brandt
Independent Non-Executive Chairman
3.5yrs
US$517.03k
0.013% $ 1.7m
Clyde Hosein
Director
0.50yr
no data
no data
Harry M. Kraemer
Independent Director
5.08yrs
US$278.57k
0.059% $ 7.7m
Betsy Holden
Independent Director
3.17yrs
US$321.32k
0.0042% $ 555.9k
Michael Alfano
Independent Director
20.08yrs
US$271.25k
0.0050% $ 654.5k
Leslie Varon
Independent Director
3.17yrs
US$278.75k
0% $ 0
Gregory Lucier
Independent Director
1.83yrs
US$256.42k
0.0061% $ 800.4k
Arthur Kowaloff
Independent Director
5.08yrs
US$267.50k
0.019% $ 2.5m
William Deese
Independent Director
10.08yrs
US$283.75k
0.0069% $ 910.8k
Janet Vergis
Independent Director
1.5yrs
US$162.13k
no data
3.3yrs
Average Tenure
63.5yo
Average Age
Experienced Board: XRAY's board of directors are considered experienced (3.3 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
DENTSPLY SIRONA Inc.'s company bio, employee growth, exchange listings and data sources
DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental products and technologies, and other consumable dental products and equipment primarily for the professional dental market w...
Company Analysis and Financial Data Status
All financial data provided by Standard & Poor's Capital IQ.
Data
Last Updated (UTC time)
Company Analysis
2021/03/07 23:13
End of Day Share Price
2021/03/05 00:00
Earnings
2020/12/31
Annual Earnings
2020/12/31
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.